These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 25383737)

  • 1. Current position of high-resolution MS for drug quantification in clinical & forensic toxicology.
    Meyer MR; Helfer AG; Maurer HH
    Bioanalysis; 2014 Aug; 6(17):2275-84. PubMed ID: 25383737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perspectives of liquid chromatography coupled to low- and high-resolution mass spectrometry for screening, identification, and quantification of drugs in clinical and forensic toxicology.
    Maurer HH
    Ther Drug Monit; 2010 Jun; 32(3):324-7. PubMed ID: 20418802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple stage MS in analysis of plasma, serum, urine and in vitro samples relevant to clinical and forensic toxicology.
    Meyer GM; Maurer HH; Meyer MR
    Bioanalysis; 2016; 8(5):457-81. PubMed ID: 26924594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current role of ICP-MS in clinical toxicology and forensic toxicology: a metallic profile.
    Goullé JP; Saussereau E; Mahieu L; Guerbet M
    Bioanalysis; 2014 Aug; 6(17):2245-59. PubMed ID: 25383735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current role of liquid chromatography-mass spectrometry in clinical and forensic toxicology.
    Maurer HH
    Anal Bioanal Chem; 2007 Aug; 388(7):1315-25. PubMed ID: 17377775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-Resolution Mass Spectrometry for Untargeted Drug Screening.
    Wu AH; Colby J
    Methods Mol Biol; 2016; 1383():153-66. PubMed ID: 26660184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of liquid chromatography-high-resolution mass spectrometry (LC-HR/MS) in clinical toxicology.
    Wu AH; Gerona R; Armenian P; French D; Petrie M; Lynch KL
    Clin Toxicol (Phila); 2012 Sep; 50(8):733-42. PubMed ID: 22888997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current applications of high-resolution mass spectrometry in drug metabolism studies.
    Meyer MR; Maurer HH
    Anal Bioanal Chem; 2012 May; 403(5):1221-31. PubMed ID: 22349341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What is the future of (ultra) high performance liquid chromatography coupled to low and high resolution mass spectrometry for toxicological drug screening?
    Maurer HH
    J Chromatogr A; 2013 May; 1292():19-24. PubMed ID: 22964051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyphenated high-resolution mass spectrometry-the "all-in-one" device in analytical toxicology?
    Maurer HH
    Anal Bioanal Chem; 2021 Apr; 413(9):2303-2309. PubMed ID: 33247339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in analytical toxicology: the current role of liquid chromatography-mass spectrometry in drug quantification in blood and oral fluid.
    Maurer HH
    Anal Bioanal Chem; 2005 Jan; 381(1):110-8. PubMed ID: 15309372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current use of high-resolution mass spectrometry in drug screening relevant to clinical and forensic toxicology and doping control.
    Ojanperä I; Kolmonen M; Pelander A
    Anal Bioanal Chem; 2012 May; 403(5):1203-20. PubMed ID: 22302167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyphenated mass spectrometric techniques-indispensable tools in clinical and forensic toxicology and in doping control.
    Maurer HH
    J Mass Spectrom; 2006 Nov; 41(11):1399-413. PubMed ID: 17051522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chiral drug analysis using mass spectrometric detection relevant to research and practice in clinical and forensic toxicology.
    Schwaninger AE; Meyer MR; Maurer HH
    J Chromatogr A; 2012 Dec; 1269():122-35. PubMed ID: 22858363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of mass spectrometry to hair analysis for forensic toxicological investigations.
    Vincenti M; Salomone A; Gerace E; Pirro V
    Mass Spectrom Rev; 2013; 32(4):312-32. PubMed ID: 23165962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances of liquid chromatography-(tandem) mass spectrometry in clinical and forensic toxicology.
    Peters FT
    Clin Biochem; 2011 Jan; 44(1):54-65. PubMed ID: 20709050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liquid chromatography-mass spectrometry in forensic and clinical toxicology.
    Maurer HH
    J Chromatogr B Biomed Sci Appl; 1998 Aug; 713(1):3-25. PubMed ID: 9700550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug confirmation by mass spectrometry: Identification criteria and complicating factors.
    Yuan C; Chen D; Wang S
    Clin Chim Acta; 2015 Jan; 438():119-25. PubMed ID: 25182671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous screening and quantification of 52 common pharmaceuticals and drugs of abuse in hair using UPLC-TOF-MS.
    Nielsen MK; Johansen SS; Dalsgaard PW; Linnet K
    Forensic Sci Int; 2010 Mar; 196(1-3):85-92. PubMed ID: 20061098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ESI-MS-MS library of 1,253 compounds for application in forensic and clinical toxicology.
    Sauvage FL; Marquet P
    Anal Bioanal Chem; 2010 Mar; 396(5):1947. PubMed ID: 20107771
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.